Related Experiment Videos
[Clinical experience with amoxicillin (Pacetocin 'Kyowa') in urology (author's transl)]
The Japanese Journal of Antibiotics
|January 1, 1976
Abstract:
Amoxicillin (Pacetocin 'Kyowa') was orally administered in a daily dose of 1 g (potency) to 5 cases with urological infections and 15 cases with postoperative infections. As a result the drug was found remarkably effective in one case, effective in 15 cases and ineffective in 3 cases; in one case, the response to amoxicillin was uninterpretable. No severe side effect was observed during the treatment.
Insights
Amoxicillin demonstrated significant efficacy in treating urological and postoperative infections. This antibiotic showed a favorable safety profile with no severe side effects observed in patients.
Area of Science:
- Pharmacology
- Infectious Diseases
- Urology
Context:
- Amoxicillin is a widely used antibiotic.
- Urological and postoperative infections pose significant clinical challenges.
- Evaluating the efficacy and safety of antibiotics is crucial for patient outcomes.
Purpose:
- To assess the clinical effectiveness of amoxicillin in patients with urological and postoperative infections.
- To determine the safety profile of orally administered amoxicillin in a clinical setting.
Summary:
- Amoxicillin was administered orally at a daily dose of 1g to 20 patients (5 with urological infections, 15 with postoperative infections).
- The treatment yielded remarkable efficacy in one case, effectiveness in 15 cases, and was ineffective in 3 cases. One case had an uninterpretable response.
- No severe adverse events were reported during the study period, indicating a good safety profile.
Impact:
- The findings support the use of amoxicillin as a treatment option for specific bacterial infections.
- This study contributes to the understanding of amoxicillin's real-world effectiveness and tolerability in clinical practice.
- Further research may explore optimal dosing and patient selection for amoxicillin therapy.